327 related articles for article (PubMed ID: 24290284)
1. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
[TBL] [Abstract][Full Text] [Related]
2. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
3. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.
Tirosh I; Yamazaki Y; Frugoni F; Ververs FA; Allenspach EJ; Zhang Y; Burns S; Al-Herz W; Noroski L; Walter JE; Gennery AR; van der Burg M; Notarangelo LD; Lee YN
J Allergy Clin Immunol; 2019 Feb; 143(2):726-735. PubMed ID: 29772310
[TBL] [Abstract][Full Text] [Related]
4. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
5. Three faces of recombination activating gene 1 (RAG1) mutations.
Patiroglu T; Akar HH; Van Der Burg M
Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
[TBL] [Abstract][Full Text] [Related]
6. Compound heterozygous mutation of Rag1 leading to Omenn syndrome.
Matthews AG; Briggs CE; Yamanaka K; Small TN; Mooster JL; Bonilla FA; Oettinger MA; Butte MJ
PLoS One; 2015; 10(4):e0121489. PubMed ID: 25849362
[TBL] [Abstract][Full Text] [Related]
7. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.
Brauer PM; Pessach IM; Clarke E; Rowe JH; Ott de Bruin L; Lee YN; Dominguez-Brauer C; Comeau AM; Awong G; Felgentreff K; Zhang YH; Bredemeyer A; Al-Herz W; Du L; Ververs F; Kennedy M; Giliani S; Keller G; Sleckman BP; Schatz DG; Bushman FD; Notarangelo LD; Zúñiga-Pflücker JC
Blood; 2016 Aug; 128(6):783-93. PubMed ID: 27301863
[TBL] [Abstract][Full Text] [Related]
8. Omenn syndrome does not live by V(D)J recombination alone.
Marrella V; Maina V; Villa A
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
10. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
[TBL] [Abstract][Full Text] [Related]
11. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
12. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
13. N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements.
Noordzij JG; Verkaik NS; Hartwig NG; de Groot R; van Gent DC; van Dongen JJ
Blood; 2000 Jul; 96(1):203-9. PubMed ID: 10891452
[TBL] [Abstract][Full Text] [Related]
14. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.
Giblin W; Chatterji M; Westfield G; Masud T; Theisen B; Cheng HL; DeVido J; Alt FW; Ferguson DO; Schatz DG; Sekiguchi J
Blood; 2009 Mar; 113(13):2965-75. PubMed ID: 19126872
[TBL] [Abstract][Full Text] [Related]
15. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
[No Abstract] [Full Text] [Related]
17. Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.
Horowitz JE; Bassing CH
J Immunol; 2014 Feb; 192(4):1609-19. PubMed ID: 24415779
[TBL] [Abstract][Full Text] [Related]
18.
Chen R; Lukianova E; van der Loeff IS; Spegarova JS; Willet JDP; James KD; Ryder EJ; Griffin H; IJspeert H; Gajbhiye A; Lamoliatte F; Marin-Rubio JL; Woodbine L; Lemos H; Swan DJ; Pintar V; Sayes K; Ruiz-Morales ER; Eastham S; Dixon D; Prete M; Prigmore E; Jeggo P; Boyes J; Mellor A; Huang L; van der Burg M; Engelhardt KR; Stray-Pedersen A; Erichsen HC; Gennery AR; Trost M; Adams DJ; Anderson G; Lorenc A; Trynka G; Hambleton S
Sci Immunol; 2024 May; 9(95):eade5705. PubMed ID: 38787962
[TBL] [Abstract][Full Text] [Related]
19. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency.
Kumaki S; Villa A; Asada H; Kawai S; Ohashi Y; Takahashi M; Hakozaki I; Nitanai E; Minegishi M; Tsuchiya S
Blood; 2001 Sep; 98(5):1464-8. PubMed ID: 11520796
[TBL] [Abstract][Full Text] [Related]
20. A variant of RAG1 gene identified in severe combined immunodeficiency: a case report.
Zhang X; Kang X; Yang M; Cai Z; Song Y; Zhou X; Cao J; Wang C; Huang K; Peng Y; He J; Xiao Z
BMC Pediatr; 2023 Feb; 23(1):56. PubMed ID: 36732712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
